A Study of the Pharmacokinetics of Golimumab in Japanese and Caucasian Male Subjects

NCT01258777 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

49

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy Volunteers

Interventions

DRUG: 400 mg golimumab or placebo
DRUG: 200 mg golimumab or placebo

Sponsor

Centocor, Inc.